The work has been led by the Biomarkers and laboratory precision medicine in hepatology, metabolism, and rare diseases (HEMERA-Lab) group from Clín...
A study coordinated by Clínic‑IDIBAPS and published in JAMA demonstrates that adding a pharmacological treatment to thrombectomy improves functiona...
According to the EXULTANT trial, adding molecular tests on sputum, urine and stool samples does not appear to outperform the standard WHO-recommend...
The awards, each worth €30.000, recognize researchers who have developed a long-standing scientific career with international impact.
The Liver vascular biology research group at IDIBAPS, in a paper published in the journal BMC Medicine, has presented three new hepatic biomarkers...
A team from Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Centre, has participated in an international study th...
Josep Dalmau, head of the Pathogenesis of autoimmune neuronal disorders group at IDIBAPS–CaixaResearch Institute and consultant in the Neurology De...
The IDIBAPS Management Committee has approved the leadership transition of the research group "Viral, genetic and immune-mediated liver diseases"....
Increasing the consumption of ultra-processed foods between the second and third trimesters of pregnancy is associated with more than double the ri...
